Can Fite Biofarma Ltd (CANF)
2.03
-0.06
(-2.87%)
USD |
NYAM |
May 02, 16:00
2.09
+0.06
(+2.96%)
After-Hours: 20:00
Can Fite Biofarma Revenue (Quarterly): 0.155M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.155M |
| September 30, 2023 | 0.196M |
| June 30, 2023 | 0.196M |
| March 31, 2023 | 0.196M |
| December 31, 2022 | 0.197M |
| September 30, 2022 | 0.204M |
| June 30, 2022 | 0.204M |
| March 31, 2022 | 0.205M |
| December 31, 2021 | 0.204M |
| September 30, 2021 | 0.251M |
| June 30, 2021 | 0.25M |
| March 31, 2021 | 0.148M |
| December 31, 2020 | 0.15M |
| September 30, 2020 | 0.211M |
| June 30, 2020 | 0.204M |
| March 31, 2020 | 0.198M |
| December 31, 2019 | 0.192M |
| September 30, 2019 | 1.152M |
| June 30, 2019 | 0.389M |
| March 31, 2019 | 0.299M |
| December 31, 2018 | 0.289M |
| September 30, 2018 | 2.629M |
| June 30, 2018 | 0.27M |
| March 31, 2018 | 0.632M |
| December 31, 2017 | 0.085M |
| Date | Value |
|---|---|
| September 30, 2017 | 0.568M |
| June 30, 2017 | 0.068M |
| March 31, 2017 | 0.068M |
| December 31, 2016 | -0.0063M |
| September 30, 2016 | 0.0603M |
| June 30, 2016 | 0.0544M |
| March 31, 2016 | 0.0566M |
| December 31, 2015 | 0.027M |
| September 30, 2015 | 0.066M |
| June 30, 2015 | 0.0717M |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | 0.1114M |
| September 30, 2011 | 0.1191M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.148M
Minimum
Mar 2021
1.152M
Maximum
Sep 2019
0.258M
Average
0.204M
Median
Jun 2020
Revenue (Quarterly) Benchmarks
| Compugen Ltd | 33.46M |
| Pluri Inc | 0.105M |
| BioLine Rx Ltd | 4.80M |
| XTL Biopharmaceuticals Ltd | -- |
| BiomX Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.652M |
| Total Expenses (Quarterly) | 1.989M |
| EPS Diluted (Quarterly) | -1.517 |
| Enterprise Value | 1.208M |
| Profit Margin (Quarterly) | -1.07K% |
| Earnings Yield | -147.8% |
| Normalized Earnings Yield | -147.78 |